News | August 15, 2012

Two Major Providers Announce Alliance to Provide Commissioning Services for Sensus SRT-100

August 15, 2012 — Mission Search Corp., a Tampa, Fla.-based healthcare search and staffing organization, announced it has joined with Sensus Healthcare to provide commissioning services to Sensus’ clientele.

Sensus Healthcare is taking new aim by focusing on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, noninvasive treatment of non-melanoma skin cancers. The company’s SRT-100 meets the safety requirements set by the U.S. Food and Drug Administration (FDA), UL and ISO/CE mark certification.

Based in Boca Raton, Fla., Sensus Healthcare employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations and product reliability.

“We are pleased to partner with Sensus Healthcare to provide medical physics commissioning services for their superficial radiation therapy (SRT) systems and ultimately assisting Sensus as it brings non-melanoma skin cancer treatment to more patients in more settings,” said John Astrab, president and CEO of Mission Search Corp.

Added Joe Sardano, president and CEO of Sensus Healthcare: “We are excited to be partnering with the Mission Search team. We both share the same values when it comes to customer service and satisfaction. We are very much looking forward to growing our business with another great partner as the need for SRT continues to evolve.”

For more information: www.sensushealthcare.com, www.missionsearch.com

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...